# Granite Bio funding rounds and investors

As of 14 Oct 2026, Granite Bio has raised $100M across 2 verified rounds on record; latest: $70 million Series B led by Forbion and Sanofi Ventures, announced 24 Apr 2025.

Granitebio is a biotechnology company developing innovative therapies focusing on inflammatory, autoimmune, and fibrotic diseases with first-in-class antibodies.

Website: https://granitebio.com  
Page: https://fireround.dev/companies/granitebio.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-04-24 | Series B | $70 million | Forbion, Sanofi Ventures | none named | [granitebio.com](https://www.granitebio.com/news/granite-bio-debuts-with-100-million-of-capital) |
| 2025-04-24 | Series A | $30 million | Versant Ventures, Novartis | none named | [granitebio.com](https://www.granitebio.com/news/granite-bio-debuts-with-100-million-of-capital) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.